RIST, a Molecularly Targeted Multimodal Strategy for Patients with Relapsed and Refractory Neuroblastoma, Demonstrated Superior Activity in Neuroblastoma Cell Lines Positive for MYCN

Leister, J. and Corbacioglu, S. and Malaise, M. (2016) RIST, a Molecularly Targeted Multimodal Strategy for Patients with Relapsed and Refractory Neuroblastoma, Demonstrated Superior Activity in Neuroblastoma Cell Lines Positive for MYCN. PEDIATRIC BLOOD & CANCER, 63 (Suppl3). S211. ISSN 1545-5009, 1545-5017

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation
Medicine > Lehrstuhl für Kinder- und Jugendmedizin
Depositing User: Petra Gürster
Date Deposited: 27 Aug 2020 11:09
Last Modified: 27 Aug 2020 11:11
URI: https://pred.uni-regensburg.de/id/eprint/4000

Actions (login required)

View Item View Item